method: The medical device uses electric impulses that are delivered to the main branch of the trigeminal nerve to prevent and treat pain in the head area. This method can replace or considerably reduce the consumption of painkilling medication and helps to find a better quality of life.
Cefaly is the perfect solution for more than half of migraine sufferers. It enables the use of medicines to be significantly reduced and the sufferer's quality of life to be markedly improved. Several published clinical studies have demonstrated its excellent effectiveness and its complete safety. Cefaly bears the CE Medical mark, is certified to the ISO Medical standard. Cefaly is positioned on the forehead using an adhesive electrode. Precise impulses are produced, which act on the trigeminal nerve in order to reduce pain and prevent migraine attacks.
Migraine affects 15% of the general population and is responsible of the highest socio-economic cost within brain disorders. CEFALY Technology follows numerous research and development pathways in order to solve this problem. Ultimately, if someone suffers from migraine or another type of primary headache, CEFALY Technology will offer the treatment of choice and the solution. CEFALY Technology is a medical company with a field of activities that covers various therapeutic means: biotechnology, pharmaceutical and medical devices.
A highly skilled team of engineers and medical doctors collaborates with several universities on international research projects. For instance : the large European research program EUROHEADPAIN in which eleven research centers and universities in Europe collaborate with CEFALY Technology (STX-Med) as only company partner for clinical investigations on chronic migraine.
The therapeutic progresses brought by CEFALY Technology's innovations will also be able to benefit to other parts of neurology (insomnia, depression, epilepsy, tinnitus, Alzheimer, ...)